Novo lost semaglutide patent protection in India, triggering generic launches. Indian drugmakers launched generic versions at lower prices. Novo cut prices and used partnerships to defend market share ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

President Trump wants pharmaceutical production to return to the United States. A shuttered factory in Louisiana shows how hard that will be for generic medicines. Dr. Reddy’s, an Indian generic ...

BILOXI, Miss. (WLOX) - All West-bound lanes are blocked after Biloxi PD responded to two car crashes on I-10 at exit 44. The first crash happened just east of the exit 44 ramp. The second crash ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

Markets remain range-bound amid festive season optimism. Autos gain on GST & interest rate cuts, IT shows resilience despite H-1B visa updates, and pharma stays robust with generics insulated from U.S ...

The Trump administration has excluded generic drugs from a baseline 15% tariff on imports from Japan under a new trade deal between the two countries. The “reciprocal” tariffs on Japanese products are ...

Sun Pharmaceutical and its Taro Pharmaceutical subsidiary are washing their hands of another segment of a years-long antitrust debacle with a $200 million settlement. The deal will clear all claims ...

Meitheal has launched paclitaxel protein-bound particles for injectable suspension (albumin-bound), through an exclusive license and supply agreement with its parent company, Hong Kong King-Friend ...

Meitheal, through parent company Hong Kong King-Friend, launches generic paclitaxel Protein-bound paclitaxel formulation is used to treat various types of cancer, including metastatic breast cancer ...